SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 3 of 37
Conferences
Pfizer CEO Albert Bourla wants to tap ‘Chinese science’ as the drug company looks for a new target after COVID
By
Lionel Lim
October 12, 2023
Health
Septuagenarian billionaire twins from Germany are quietly remaking the world of health care—and it all started with a vaccine
By
Ben Stupples
and
Bloomberg
August 8, 2023
Health
Pfizer plant’s tornado damage may exacerbate existing shortages of critical drugs
By
Ike Swetlitz
and
Bloomberg
July 21, 2023
Health
Pfizer plant in North Carolina heavily damaged by tornado ‘will likely lead to long-term shortages’ of drugs
By
Ben Finley
,
Hannah Schoenbaum
and
The Associated Press
July 20, 2023
Health
If you’re pregnant, you can now get a vaccine that protects you and your child from a dangerous respiratory virus
By
Lauran Neergaard
and
The Associated Press
May 18, 2023
Newsletters
Pfizer’s chief corporate affairs officer remembers the moment she figured out how to ‘break through’ to skeptical consumers during COVID
By
Sally Susman
and
Kinsey Crowley
March 28, 2023
Health
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
By
Arthur Allen
and
Kaiser Health News
November 8, 2022
Health
Europe’s drug regulator set to approve Moderna and Pfizer Omicron boosters this week
By
Lyubov Pronina
and
Bloomberg
August 31, 2022
Newsletters
How Zoetis’s CEO is catering to the hands-on millennial pet owner
By
Emma Hinchliffe
and
Paige McGlauflin
August 30, 2022
Health
Pfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
By
Chloe Taylor
August 26, 2022
Health
An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data
By
Nicholas Gordon
August 24, 2022
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By
Paige McGlauflin
August 15, 2022
Commentary
COVID finally got me. Will it come for you?
By
Carolyn Barber
July 12, 2022
Health
FDA authorizes Pfizer and Moderna COVID vaccines for children under 5
By
Fiona Rutherford
and
Bloomberg
June 17, 2022
Leadership
These are the most inspirational CEOs on the Fortune 500
By
Marco Quiroz-Gutierrez
May 26, 2022
Most Popular
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
AI
Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
By
Nick Lichtenberg
Success
Blackstone exec says elite Ivy League degrees aren’t good enough—new analysts need to ‘work harder’ and be nice
By
Ashley Lutz